Abeprazan is a compound under investigation in clinical trials for its potential use as a potassium-competitive acid blocker. It is studied for applications in acute or chronic gastritis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1902954-60-2
Abeprazan hydrochloride
pharmaceutical raw material
Tegoprazan
pharmaceutical raw material
TAK 438
pharmaceutical raw material
Revaprazan hydrochloride
pharmaceutical raw material
Vonoprazan Fumarate
pharmaceutical raw material
Bepotastine besilate
pharmaceutical raw material
Pramipexole dihydrochloride hydrate
pharmaceutical raw material
Ruxolitinib hydrochloride
pharmaceutical raw material
1-[5-(2,4-difluorophenyl)-1-(3-fluorophenyl)sulfonyl-4-methoxypyrrol-3-yl]-N-methylmethanamine
OUNXGNDVWVPCOL-UHFFFAOYSA-N
CNCC1=CN(C(=C1OC)C2=C(C=C(C=C2)F)F)S(=O)(=O)C3=CC=CC(=C3)F